Biocon Limited ( ($IN:BIOCON) ) has issued an update. Biocon Limited has significantly increased its stake in its unlisted material subsidiary, ...

Mumbai: Biocon has announced plans to fully merge Biocon Biologics Limited (BBL) into the parent company by making it a wholly owned subsidiary. To achieve this, Biocon will acquire the minority ...

Ajanta Pharma shares gained 3% despite a weak market as analysts turned bullish on its Biocon partnership, semaglutide ...

Biocon Limited has been actively involved in corporate actions. A meeting of the Board of Directors is scheduled for August 7, 2025, to review and approve the unaudited standalone and consolidated ...

On Thursday, Phillip Securities adjusted its outlook on Biocon Ltd (BSE:BIOS), reducing the stock's price target to INR280 from INR330, while maintaining a Neutral rating. The revision follows ...

Biocon extended its winning run on Thursday, rising as much as 3.9 per cent to a day’s high of Rs 422.60 against its previous close of Rs 406.35. The stock has surged nearly 10 per cent over the past ...

Shares of Biocon declined by 2.72% to Rs 334.00 in Monday's early trading session. The decline positions the stock among the top losers on the Nifty Midcap 150. Mar 2021: Rs 7,105.80 Crore Mar 2022: ...

On October 23, Biocon will be reporting earnings Q2. Analysts expect Biocon will report earnings per share of INR 1.84. Go here to watch Biocon stock price in real-time ahead of earnings. On October ...

According to PL Capital, Ajanta Pharma's strong franchise will aid in garnering a higher market share for semaglutide ...

Biocon Ltd. Annual cash flow by MarketWatch. View BIOCON net cash flow, operating cash flow, operating expenses and cash dividends.

Biocon Limited ( ($IN:BIOCON) ) just unveiled an update. Biocon Limited has increased its ownership in its unlisted material subsidiary, Biocon ...